What did @aaronw.reed actually say?
Aaron Reed is celebrating the FDA's removal of the black box warning from testosterone products, arguing this vindicates TRT and proves the hormone has been unfairly demonized. He frames it as a cultural win, compares testosterone to insulin, and suggests modern environmental exposures are systematically suppressing men's testosterone levels. He also claims older men relying on multiple medications would be better served by testosterone replacement alone.
He made several specific arguments worth unpacking: that testosterone is a bioidentical hormone with a long safety record, that everyday environmental factors are non-accidentally lowering testosterone, and that the COVID vaccine received a black box warning while testosterone lost one. He rounds out the video by dismissing skeptics of TRT as "stupid" and encouraging viewers to DM him about hormone therapy.
Does the science back this up?
Partially. The FDA did revise testosterone labeling in 2024, removing the cardiovascular warning that had been added in 2015. But the rest of Reed's claims range from oversimplified to outright misleading.
On the black box comparison: the mRNA COVID vaccines received a myocarditis warning for adolescent males, not a general black box, and that is a distinct regulatory category. Treating these as equivalent swaps is a rhetorical move, not a scientific one.
On environmental testosterone disruption: there is legitimate evidence that endocrine-disrupting chemicals, including phthalates and BPA, can lower testosterone. Travison et al. (2007, Journal of Clinical Endocrinology and Metabolism) documented a population-level decline in male testosterone over decades, and researchers have pointed to obesity, sedentary behavior, and environmental chemical exposure as probable contributors. Reed is not wrong that the modern environment is not neutral here. But his claim that "not one thing we do in our daily" accidentally raises testosterone ignores exercise, sleep, and dietary fat, all of which have documented effects on testosterone levels.
On replacing multiple medications with testosterone: this is the most dangerous overreach in the video. There is no clinical basis for the claim that testosterone can replace most medications in elderly men. This is not just unsupported, it is potentially harmful advice.
What did they get wrong (or right)?
Reed gets partial credit for the basics. Testosterone is a naturally occurring hormone. Symptomatic hypogonadism is underdiagnosed and undertreated. The 2015 cardiovascular warning was added following the TLANDO/Bhasin-era controversy and faced ongoing scientific dispute. Its removal reflects updated evidence, including the TRAVERSE trial (Lincoff et al., 2023, New England Journal of Medicine), which found testosterone replacement did not increase major cardiovascular events in men with hypogonadism and elevated cardiovascular risk.
But he gets several things wrong. Calling women on hormonal contraception "steroid users" in the same breath as TRT patients is technically defensible at a molecular level but contextually misleading. Synthetic progestins and ethinyl estradiol are not bioidentical and carry different receptor profiles than endogenous hormones. The comparison generates heat, not light.
His claim that "testosterone is not a steroid" followed immediately by admitting it is "technically a steroid hormone" is just confusing. He's probably trying to separate it from anabolic-androgenic steroid abuse, a fair distinction, but he muddies it.
The most irresponsible line in the video is suggesting older men should replace "90 pills" with testosterone. That is not how polypharmacy works, and no credentialed clinician would say otherwise.
What should you actually know?
The FDA labeling change is real and meaningful. The 2023 TRAVERSE trial was the largest randomized trial of testosterone in older men with hypogonadism to date, enrolling over 5,200 participants, and it did not find increased rates of major adverse cardiac events compared to placebo. That was the evidence basis for reconsidering the warning language.
What TRT is appropriate for: diagnosed hypogonadism, confirmed by two morning serum testosterone measurements below 300 ng/dL with accompanying symptoms, per Endocrine Society guidelines (Bhasin et al., 2018). It is not a general wellness intervention for men with low-normal levels.
Environmental endocrine disruption is a legitimate research area. Swan et al. (2021, Count Down) and multiple epidemiological studies have linked phthalate exposure to reduced testosterone. But the causal picture is complicated, and the leap from "chemicals exist" to "everything is by design" is conspiratorial, not scientific.
If you are considering TRT, the conversation starts with a lab panel and a physician, not a DM to an influencer. Testosterone therapy has real risks including erythrocytosis, sleep apnea exacerbation, infertility, and potential effects on lipid profiles that require monitoring.